ArticleOncoTargets and therapy2015

Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma.

Lei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.